Quarterly report pursuant to Section 13 or 15(d)

Note 16 - Commitments and Contingencies (Details)

v3.10.0.1
Note 16 - Commitments and Contingencies (Details)
 3 Months Ended 12 Months Ended
Jul. 31, 2018
USD ($)
shares
Jul. 27, 2018
USD ($)
Jul. 01, 2018
USD ($)
shares
Apr. 06, 2018
USD ($)
Jan. 05, 2018
USD ($)
Nov. 30, 2017
USD ($)
shares
Oct. 09, 2017
USD ($)
Aug. 23, 2017
USD ($)
Jul. 20, 2016
USD ($)
Mar. 31, 2016
USD ($)
Aug. 01, 2015
USD ($)
shares
Oct. 01, 2014
USD ($)
Aug. 31, 2018
USD ($)
shares
Aug. 31, 2017
USD ($)
May 31, 2018
USD ($)
Apr. 17, 2017
ft²
Note 16 - Commitments and Contingencies (Details) [Line Items]                                
Loss Contingency Accrual, Provision                             $ 10,000  
Debt Conversion, Original Debt, Amount                         $ 0 $ 62,500    
Employee-related Liabilities, Current                         38,203   44,465  
Allocated Share-based Compensation Expense   $ 4,375                     120,138 $ 0    
Chief Executive Officer [Member]                                
Note 16 - Commitments and Contingencies (Details) [Line Items]                                
Employment Agreement, Term                       5 years        
Salary and Wage, Officer, Excluding Cost of Good and Service Sold     $ 150,000                 $ 150,000        
Deferred Compensation Arrangement with Individual, Description     performance bonus equal to 2% of the annual EBITDA of CLS Nevada, Inc., and annual restricted stock awards of the Company’s common stock in an amount equal to 3% of the annual EBITDA of CLS Nevada, Inc                 performance bonus equal to 2% of CLS Labs’ annual EBITDA, up to a maximum annual cash compensation of $1 million (including his base salary), and annual stock options, exercisable at the fair market value of CLS Labs’ common stock on the date of grant, in an amount equal to 2% of its annual EBITDA up to $42.5 million and 4% of its annual EBITDA in excess of $42.5 million        
Share-based Compensation Arrangement by Share-based Payment Award, Description                       annual stock options, exercisable at the fair market value of CLS Labs’ common stock on the date of grant, in an amount equal to 2% of its annual EBITDA up to $42.5 million and 4% of its annual EBITDA in excess of $42.5 million        
Employee-related Liabilities, Current                         0   37,500  
Accrued Salaries                         $ 25,000   0  
Chief Operating Officer [Member]                                
Note 16 - Commitments and Contingencies (Details) [Line Items]                                
Employment Agreement, Term                     5 years          
Salary and Wage, Officer, Excluding Cost of Good and Service Sold $ 150,000                   $ 150,000          
Deferred Compensation Arrangement with Individual, Description performance bonus equal to 2% of the annual EBITDA of CLS Nevada, Inc., and annual restricted stock awards of the Company’ common stock in an amount equal to 3% of the annual EBITDA                   performance bonus equal to 2% of the Company’s annual EBITDA, up to a maximum annual cash compensation of $1 million (including his base salary), and annual stock options, exercisable at the fair market value of the Company’s common stock on the date of grant, in an amount equal to 2% of its annual EBITDA up to $42.5 million and 4% of its annual EBITDA in excess of $42.5 million          
Share-based Compensation Arrangement by Share-based Payment Award, Description                     annual stock options, exercisable at the fair market value of the Company’s common stock on the date of grant, in an amount equal to 2% of its annual EBITDA up to $42.5 million and 4% of its annual EBITDA in excess of $42.5 million          
Employee-related Liabilities, Current           $ 37,500                    
President and Chief Financial Officer [Member]                                
Note 16 - Commitments and Contingencies (Details) [Line Items]                                
Salary and Wage, Officer, Excluding Cost of Good and Service Sold           $ 175,000                    
Deferred Compensation Arrangement with Individual, Description           performance bonus equal to 2% of the Company’s annual EBITDA, and annual restricted stock awards of the Company’s common stock in an amount equal to 3% of its annual EBITDA                    
Share-based Compensation Arrangement by Share-based Payment Award, Description           annual restricted stock awards of the Company’s common stock in an amount equal to 3% of its annual EBITDA                    
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures (in Shares) | shares                         600,000      
Former Officer [Member]                                
Note 16 - Commitments and Contingencies (Details) [Line Items]                                
Employee-related Liabilities, Current                         $ 16,250   16,250  
Building [Member]                                
Note 16 - Commitments and Contingencies (Details) [Line Items]                                
Area of Real Estate Property (in Square Feet) | ft²                               14,392
Lessee, Operating Lease, Term of Contract                               72 months
Lessee, Operating Lease, Renewal Term                               10 years
Deposit [Member]                                
Note 16 - Commitments and Contingencies (Details) [Line Items]                                
Loss Contingency Accrual, Provision                             50,000  
Rent Expense [Member]                                
Note 16 - Commitments and Contingencies (Details) [Line Items]                                
Loss Contingency Accrual, Provision                             15,699  
Remaining Amounts Due Under Lease [Member]                                
Note 16 - Commitments and Contingencies (Details) [Line Items]                                
Loss Contingency Accrual, Provision                             30,000  
One Time Signing Bonus [Member] | Chief Executive Officer [Member]                                
Note 16 - Commitments and Contingencies (Details) [Line Items]                                
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in Shares) | shares 500,000   500,000                          
Allocated Share-based Compensation Expense $ 59,167                           $ 59,167  
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period 1 year   1 year                          
One Time Signing Bonus [Member] | Chief Operating Officer [Member]                                
Note 16 - Commitments and Contingencies (Details) [Line Items]                                
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in Shares) | shares 50,000                   250,000          
Allocated Share-based Compensation Expense $ 5,917                   $ 327,500          
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period 1 year                   1 year          
One Time Signing Bonus [Member] | President and Chief Financial Officer [Member]                                
Note 16 - Commitments and Contingencies (Details) [Line Items]                                
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in Shares) | shares           500,000                    
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period           1 year                    
Unpaid Accrued Salary Converted to Convertible Note [Member] | Convertible Debt [Member] | Chief Executive Officer [Member]                                
Note 16 - Commitments and Contingencies (Details) [Line Items]                                
Debt Conversion, Original Debt, Amount       $ 37,500 $ 37,500   $ 39,521 $ 62,500 $ 250,000 $ 112,500